£128k
+11%vs Dec 2024Active06500709Private limited companyThetford
INTELLIGENT OMICS LIMITED
Significant control: Nottingham Consultants Limited (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Intelligent Omics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Intelligent Omics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
INTELLIGENT OMICS LIMITED is an active private limited company (company number 06500709) incorporated on 12 February 2008, registered in Thetford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £128k and cash of £68k, with 5 employees on average. Net assets rose 11% on the prior period (£115k).
Peer position · net assets
By net assets it sits in the top quarter of 278 comparable companies in Other (median £129, upper quartile £59k).
02
Ownership and control
- Nottingham Consultants Limited
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 12 February 200818 yrs ago
- Next accounts due
- 30 September 2027in 341 days
- Confirmation statement due
- 26 February 2027in 125 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£68k
+5606%vs Dec 2024Not reported
5
No changevs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £128k | £68k | £26k | £563k | — | — | 5 |
| 31 December 2024 | £115k | £1,200 | £71k | £513k | — | — | 5 |
Current ratio0.17Current assets ÷ creditors within one year
Cash per employee£14kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £128,115 at 31 December 2025
- Net assets up 10% or more on the prior period+10.9% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.17
- Cash at bank of £50,000 or moreCash £68,468
- Incorporated five or more years agoIncorporated 12 February 2008
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 341 days
- Confirmation statement duein 125 days
- Accounts period endNet assets £128k · small accounts
- Accounts period endNet assets £115k · small accounts
- Incorporated
08
Similar companies in the UK
- APTAMER DIAGNOSTICS LIMITEDYork · inc. Mar 2008
- X - MET LTDNewton Abbot · inc. Apr 2008
- BRAINWAVE-DISCOVERY LIMITEDGartmore · inc. Sept 2007
- RWZ CLINICAL SERVICE LIMITEDCirencester · inc. Mar 2007
- NUGERONTIX LIMITEDStoke-On-Trent · inc. Mar 2007
- BIOMATION LTDIpswich · inc. Nov 2006
All companies incorporated on 12 February 2008 · in Feb 2008.
09
Reminders for INTELLIGENT OMICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.